| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ACTH-Secreting Neuroendocrine Carcinoma of the Cecum: Case Report and Review of the Literature
|
Mokhtar, Ahmed
|
|
2019
|
18 |
1 |
p. e163-e170
|
artikel
|
| 2 |
Association Between Primary Payer Status and Survival in Patients With Stage III Colon Cancer: An National Cancer Database Analysis
|
Ahmed, Aabra
|
|
2019
|
18 |
1 |
p. e1-e7
|
artikel
|
| 3 |
Bolus 5-fluorouracil (5-FU) In Combination With Oxaliplatin Is Safe and Well Tolerated in Patients Who Experienced Coronary Vasospasm With Infusional 5-FU or Capecitabine
|
Chakrabarti, Sakti
|
|
2019
|
18 |
1 |
p. 52-57
|
artikel
|
| 4 |
E-Cadherin in Colorectal Cancer: Relation to Chemosensitivity
|
Druzhkova, Irina
|
|
2019
|
18 |
1 |
p. e74-e86
|
artikel
|
| 5 |
Editorial Board
|
|
|
2019
|
18 |
1 |
p. A1
|
artikel
|
| 6 |
Effects of Adjuvant Chemotherapy on Cognitive Function of Patients With Early-stage Colorectal Cancer
|
Sales, Manuela Vasconcelos Castro
|
|
2019
|
18 |
1 |
p. 19-27
|
artikel
|
| 7 |
Effects of Proton Pump Inhibitors on FOLFOX and CapeOx Regimens in Colorectal Cancer
|
Wong, Grace G.
|
|
2019
|
18 |
1 |
p. 72-79
|
artikel
|
| 8 |
Efficacy and Cardiotoxic Safety Profile of Raltitrexed in Fluoropyrimidines-Pretreated or High-Risk Cardiac Patients With GI Malignancies: Large Single-Center Experience
|
Khan, Khurum
|
|
2019
|
18 |
1 |
p. 64-71.e1
|
artikel
|
| 9 |
Factors Affecting Oncologic Outcomes of 90Y Radioembolization of Heavily Pre-Treated Patients With Colon Cancer Liver Metastases
|
Kurilova, Ieva
|
|
2019
|
18 |
1 |
p. 8-18
|
artikel
|
| 10 |
Fluoropyrimidine Cardiotoxicity: Time for a Contemporaneous Appraisal
|
Upshaw, Jenica N.
|
|
2019
|
18 |
1 |
p. 44-51
|
artikel
|
| 11 |
5-Fluorouracil-related Cardiotoxicity; Findings From Five Randomized Studies of 5-Fluorouracil-based Regimens in Metastatic Colorectal Cancer
|
Abdel-Rahman, Omar
|
|
2019
|
18 |
1 |
p. 58-63
|
artikel
|
| 12 |
FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer
|
Mondaca, Sebastian
|
|
2019
|
18 |
1 |
p. e39-e52
|
artikel
|
| 13 |
Measurement of the IgM and IgG Autoantibody Immune Responses in Human Serum has High Predictive Value for the Presence of Colorectal Cancer
|
Fitzgerald, Seán
|
|
2019
|
18 |
1 |
p. e53-e60
|
artikel
|
| 14 |
Outcomes of Older Patients (≥ 70 Years) Treated With Targeted Therapy in Metastatic Chemorefractory Colorectal Cancer: Retrospective Analysis of NCIC CTG CO.17 and CO.20
|
Wells, J. Connor
|
|
2019
|
18 |
1 |
p. e140-e149
|
artikel
|
| 15 |
Pathologic Staging Inconsistency Between ypT4N0 (stage II) and ypT1-2N1 (stage III) After Preoperative Chemoradiotherapy and Total Mesorectal Excision in Rectal Cancer: A Multi-Institutional Study
|
Lee, Joo Hwan
|
|
2019
|
18 |
1 |
p. e130-e139
|
artikel
|
| 16 |
Patterns of Use, Safety, and Effectiveness of Targeted Therapies in First-Line Treatment of Metastatic Colorectal Cancer According to Age: The STROMBOLI Cohort Study
|
Gouverneur, Amandine
|
|
2019
|
18 |
1 |
p. e150-e162
|
artikel
|
| 17 |
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients With Potentially Resectable Colorectal Cancer Liver Metastases
|
Pietrantonio, Filippo
|
|
2019
|
18 |
1 |
p. 34-43.e6
|
artikel
|
| 18 |
Plasma Dynamics of RAS/RAF Mutations in Patients With Metastatic Colorectal Cancer Receiving Chemotherapy and Anti-EGFR Treatment
|
Thomsen, Caroline Brenner
|
|
2019
|
18 |
1 |
p. 28-33.e3
|
artikel
|
| 19 |
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based Chemotherapy
|
Tokunaga, Ryuma
|
|
2019
|
18 |
1 |
p. e8-e19
|
artikel
|
| 20 |
Prognostic Effect of Tumor Sidedness in Colorectal Cancer: A SEER-Based Analysis
|
Li, Yaqi
|
|
2019
|
18 |
1 |
p. e104-e116
|
artikel
|
| 21 |
Prognostic Value of Baseline ALBI Score Among Patients With Colorectal Liver Metastases: A Pooled Analysis of Two Randomized Trials
|
Abdel-Rahman, Omar
|
|
2019
|
18 |
1 |
p. e61-e68
|
artikel
|
| 22 |
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer—A UNICANCER GI-PRODIGE Trial
|
Bennouna, Jaafar
|
|
2019
|
18 |
1 |
p. e69-e73
|
artikel
|
| 23 |
Review: Pathology and Its Clinical Relevance of Mucinous Appendiceal Neoplasms and Pseudomyxoma Peritonei
|
Legué, Laura M.
|
|
2019
|
18 |
1 |
p. 1-7
|
artikel
|
| 24 |
Rising Incidence and Improved Survival of Anal Squamous Cell Carcinoma in Norway, 1987-2016
|
Guren, Marianne Grønlie
|
|
2019
|
18 |
1 |
p. e96-e103
|
artikel
|
| 25 |
Rising Proportion of Young Individuals With Rectal and Colon Cancer
|
Kasi, Pashtoon Murtaza
|
|
2019
|
18 |
1 |
p. e87-e95
|
artikel
|
| 26 |
Stromal PD-1/PD-L1 Expression Predicts Outcome in Colon Cancer Patients
|
Wyss, Jacqueline
|
|
2019
|
18 |
1 |
p. e20-e38
|
artikel
|
| 27 |
Table of Contents
|
|
|
2019
|
18 |
1 |
p. A3-A7
|
artikel
|
| 28 |
Third- or Later-line Therapy for Metastatic Colorectal Cancer: Reviewing Best Practice
|
Bekaii-Saab, Tanios
|
|
2019
|
18 |
1 |
p. e117-e129
|
artikel
|
Tijdschrift beschrijving